Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann M Reed

Showing results (71-80 of 117) with videos related to

Pageof 12
Sort By:
Pediatrics|August 1, 2019
Cultivating Research Skills During Clinical Training to Promote Pediatric-Scientist DevelopmentJillian H Hurst, Katherine J Barrett, Matthew S Kelly, et al.
Arthritis and Rheumatism|May 21, 2013
Premature cell senescence and T cell receptor-independent activation of CD8+ T cells in juvenile idiopathic arthritisJeffrey A Dvergsten, Robert G Mueller, Patricia Griffin, et al.
Clinical and Experimental Rheumatology|October 9, 2015
Interferon-regulated chemokine score associated with improvement in disease activity in refractory myositis patients treated with rituximabConsuelo M López De Padilla, Cynthia S Crowson, Molly S Hein, et al.
Arthritis Care & Research|August 29, 2013
Clinical characteristics of children with juvenile dermatomyositis: the Childhood Arthritis and Rheumatology Research Alliance RegistryAngela Byun Robinson, Mark F Hoeltzel, Dawn M Wahezi, et al.
Molecular Medicine (Cambridge, Mass.)|May 23, 2007
An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activityEmily C Baechler, Jason W Bauer, Catherine A Slattery, et al.
The Journal of Rheumatology|July 3, 2010
Treatment approaches to juvenile dermatomyositis (JDM) across North America: The Childhood Arthritis and Rheumatology Research Alliance (CARRA) JDM Treatment SurveyElizabeth Stringer, John Bohnsack, Suzanne L Bowyer, et al.
The Journal of Rheumatology|November 3, 2016
Gene Expression Profiling in Blood and Affected Muscle Tissues Reveals Differential Activation Pathways in Patients with New-onset Juvenile and Adult DermatomyositisConsuelo M López De Padilla, Cynthia S Crowson, Molly S Hein, et al.
The Journal of Rheumatology|November 3, 2016
Childhood Arthritis and Rheumatology Research Alliance Consensus Clinical Treatment Plans for Juvenile Dermatomyositis with Persistent Skin RashAdam M Huber, Susan Kim, Ann M Reed, et al.
The Journal of Rheumatology|April 15, 2026
Systematic literature review informing PReS/CARRA-endorsed recommendations for the treat-to-target strategy in juvenile dermatomyositisAna Isabel Rebollo-Giménez, Talia Baird, Brian M Feldman, et al.
Arthritis and Rheumatism|November 30, 2006
Immunogenetic risk and protective factors for juvenile dermatomyositis in CaucasiansGulnara Mamyrova, Terrance P O'Hanlon, Jason B Monroe, et al.
Pageof 12

Showing results (71-80 of 117) with videos related to

Sort By:
Pageof 12
Pediatrics|August 1, 2019
Cultivating Research Skills During Clinical Training to Promote Pediatric-Scientist DevelopmentJillian H Hurst, Katherine J Barrett, Matthew S Kelly, et al.
Arthritis and Rheumatism|May 21, 2013
Premature cell senescence and T cell receptor-independent activation of CD8+ T cells in juvenile idiopathic arthritisJeffrey A Dvergsten, Robert G Mueller, Patricia Griffin, et al.
Clinical and Experimental Rheumatology|October 9, 2015
Interferon-regulated chemokine score associated with improvement in disease activity in refractory myositis patients treated with rituximabConsuelo M López De Padilla, Cynthia S Crowson, Molly S Hein, et al.
Arthritis Care & Research|August 29, 2013
Clinical characteristics of children with juvenile dermatomyositis: the Childhood Arthritis and Rheumatology Research Alliance RegistryAngela Byun Robinson, Mark F Hoeltzel, Dawn M Wahezi, et al.
Molecular Medicine (Cambridge, Mass.)|May 23, 2007
An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activityEmily C Baechler, Jason W Bauer, Catherine A Slattery, et al.
The Journal of Rheumatology|July 3, 2010
Treatment approaches to juvenile dermatomyositis (JDM) across North America: The Childhood Arthritis and Rheumatology Research Alliance (CARRA) JDM Treatment SurveyElizabeth Stringer, John Bohnsack, Suzanne L Bowyer, et al.
The Journal of Rheumatology|November 3, 2016
Gene Expression Profiling in Blood and Affected Muscle Tissues Reveals Differential Activation Pathways in Patients with New-onset Juvenile and Adult DermatomyositisConsuelo M López De Padilla, Cynthia S Crowson, Molly S Hein, et al.
The Journal of Rheumatology|November 3, 2016
Childhood Arthritis and Rheumatology Research Alliance Consensus Clinical Treatment Plans for Juvenile Dermatomyositis with Persistent Skin RashAdam M Huber, Susan Kim, Ann M Reed, et al.
The Journal of Rheumatology|April 15, 2026
Systematic literature review informing PReS/CARRA-endorsed recommendations for the treat-to-target strategy in juvenile dermatomyositisAna Isabel Rebollo-Giménez, Talia Baird, Brian M Feldman, et al.
Arthritis and Rheumatism|November 30, 2006
Immunogenetic risk and protective factors for juvenile dermatomyositis in CaucasiansGulnara Mamyrova, Terrance P O'Hanlon, Jason B Monroe, et al.
Pageof 12